CSPC Pharmaceutical Group (HKSE:01093) Long-Term Capital Lease Obligation : HK$117 Mil (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group Long-Term Capital Lease Obligation?

CSPC Pharmaceutical Group's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$117 Mil.

CSPC Pharmaceutical Group's quarterly Long-Term Capital Lease Obligation declined from Jun. 2023 (HK$204 Mil) to Sep. 2023 (HK$0 Mil) but then increased from Sep. 2023 (HK$0 Mil) to Dec. 2023 (HK$117 Mil).

CSPC Pharmaceutical Group's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (HK$68 Mil) to Dec. 2022 (HK$288 Mil) but then declined from Dec. 2022 (HK$288 Mil) to Dec. 2023 (HK$117 Mil).

CSPC Pharmaceutical Group Long-Term Capital Lease Obligation Historical Data

The historical data trend for CSPC Pharmaceutical Group's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Long-Term Capital Lease Obligation Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

100.48

110.10

68.11

288.16

117.10

CSPC Pharmaceutical Group Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															288.16	-	204.41	-	117.10

CSPC Pharmaceutical Group (HKSE:01093) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

CSPC Pharmaceutical Group Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group (HKSE:01093) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

CSPCY:USA CHJTF:USA CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (HKSE:01093) Headlines

No Headlines